Skip to content

    Recently Viewed


      Home / Latest news /
      Healthy Minds: A Janssen report looks at mental health in Asian Pacific countries
      Mental Health Holding hands
      Mental Health Holding hands

      Healthy Minds: A Janssen report looks at mental health in Asian Pacific countries

      To commemorate World Mental Health Day, Janssen shares findings from an analysis of mental health services in 15 countries.

      Share Article
      share to

      Consider what it would be like to live with an illness that isolates you from your family, friends and community—and for which treatment may not be available.

      This is a reality for many people who experience mental illness in the Asia Pacific region.

      According to new independent research from the Economist Intelligence Unit—released today to coincide with World Mental Health Day—up to 20% of adults suffer from a diagnosable mental illness each year, but more than half of these people will never receive medical treatment.

      My brother was fortunate enough to receive quality medical care for schizophrenia, so the report’s finding touched on an issue that is close to my heart.

      Sponsored by Janssen Asia Pacific, as part of our Healthy Minds program, the report looks at efforts to implement mental health policies in 15 countries and territories across the Asia Pacific region. Among its findings:

      There’s universal support for greater access to resources. The report found there is a desire across the region to improve access to mental health resources—to move away from the days when patients were simply institutionalized toward services that allow people to remain integrated in their communities and live more meaningful lives.

      Despite that support, success varies widely among countries. Positive progress is largely related to national wealth. So for those suffering from mental illness, where they live dictates the level of care they have at their disposal.

      Stigma against mental illness remains pervasive. This is especially true for severe conditions like schizophrenia. The report notes that failure to address this stigma will undermine progress toward integrating people into their communities.

      Mental illness doesn’t just take a social toll. Even in the best-performing countries—Australia and New Zealand—mental illness reduces gross domestic product by 3.5% and 5%, respectively, due to factors such as treatment costs and lost workplace productivity.

      As a society, there is much we can do to address the report’s findings, and some of the region’s successful programs can offer a pathway for change in countries around the world. Australia’s “Don’t Be Left in the Dark” campaign, for example, is designed to provide information about schizophrenia—an often-misunderstood condition.

      Janssen Healthy Minds programs like this can go a long way toward helping to strengthen health systems, tackle stigma, educate the public and reduce the burden of mental illness on society.

      On World Mental Health Day and every day, all families deserve the support that mine has been fortunate enough to receive.

      More from Johnson & Johnson

      Health & wellness
       Intense and extreme heat wave under the sun illustrating the impact of climate change

      Building climate-resilient health clinics

      When Mother Nature strikes—think triple-digit heatwaves, wildfires, hurricanes—vulnerable populations are at risk of missing out on much-needed healthcare. For Earth Day, learn how Johnson & Johnson is helping community clinics protect patients.
      Latest news
      Q1 2024-1x1.png

      What you need to know about Johnson & Johnson’s 2024 first-quarter earnings

      Here’s an infographic breakdown of the company’s first-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
      Latest news
      healthcare worker in protective medical gear

      Johnson & Johnson named to Fortune’s 2024 America’s Most Innovative Companies list

      The company’s drive to develop novel solutions for the world’s toughest healthcare challenges has earned it a spot on Fortune’s second annual list.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.